Tiban M 20/500mg Tablet ER
Marketer
Ajanta Pharma Ltd
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Tiban M 20/500mg Tablet ER
Combiflex DM 20/500mg Extended-Release Tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications, such as vision impairment and kidney dysfunction, and may also lessen the risk of cardiovascular events like stroke or heart attack. Combiflex DM 20/500mg ER may be utilized as a monotherapy or in conjunction with other antidiabetic agents. Optimal therapeutic outcomes are achieved when coupled with a balanced diet and consistent physical activity. Dosage is tailored to individual needs, factoring in current health status, glucose levels, and other medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician guidance. The medication actively regulates blood sugar, proactively reducing future complications. Adherence to the prescribed diet and exercise regimen is vital. Lifestyle choices significantly influence diabetes management. Common side effects include nausea, vomiting, diarrhea, abdominal upset, and headache. Hypoglycemia, particularly when used concurrently with insulin or sulfonylureas, is a potential side effect requiring recognition and appropriate management. This medication is not universally suitable. Prior to initiating treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Drug interactions are possible; disclose all current medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout the treatment period.
Primary Ingredients of Tiban M 20/500mg Tablet ER
No text provided to rephrase.
Uses of Tiban M 20/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Tiban M 20/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tiban M 20/500mg Extended-Release Tablets. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
Common Side effects of Tiban M 20/500mg Tablet ER:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Tiban M 20/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tiban M 20/500mg Extended-Release tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medicine with a meal.
How Tiban M 20/500mg Tablet ER works:
Extended-release Tiban M tablets (20mg/500mg) contain a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tiban M 20/500mg Extended-Release Tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Tiban M 20/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Tiban M 20/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tiban M 20/500mg Tablet ER on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Tiban M 20/500mg Extended-Release Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Tiban M 20/500mg Extended-Release Tablets. Physician consultation is essential. Regular kidney function assessments are recommended during treatment.
LiverUNSAFE
Extended-release Tiban M 20/500mg tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.
What if you forget to take Tiban M 20/500mg Tablet ER :
Should you forget to take a Tiban M 20/500mg Extended-Release Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tiban M 20/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |






